SEARCH:

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, November 12, 2021 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such. 

1.

Details of the person discharging managerial responsibilities/person   closely associated  

a)

Name

Paul Chaplin

2.

Reason for the notification

a)

Position/status

 

President and   Chief Executive Officer of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial   notification

3.

Details of the issuer, emission allowance market participant, auction   platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type   of instrument; (ii) each type of transaction; (iii) each date; and (iv) each   place where transactions have been conducted

a)

Description of the financial instrument, type of instrument
 
 

Identification code

Warrants


 
  DK0015998017

b)

Nature of the transaction

Grant

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 0.00

105,159

d)

Aggregated   information

-           Aggregated   volume

-           Price

 

105,159

DKK 0.00

e)

Date of the transaction

2021-11-12

f)

Place of the transaction

Outside a   trading venue

  

1.

Details of the   person discharging managerial responsibilities/person closely associated  

a)

Name

Henrik Juuel

2.

Reason for the   notification

a)

Position/status

 

Executive Vice President and Chief Financial Officer   of Bavarian Nordic A/S

b)

Initial   notification/Amendment

Initial notification

3.

Details of the   issuer, emission allowance market participant, auction platform, auctioneer   or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s):   section to be repeated for (i) each type of instrument; (ii) each type of   transaction; (iii) each date; and (iv) each place where transactions have   been conducted

a)

Description of   the financial instrument, type of instrument
 
 

Identification   code

Warrants


 
  DK0015998017

b)

Nature of the   transaction

Grant

c)

Price(s) and   volume(s)

Price(s)

Volume(s)

 

 

DKK 0.00

31,871

d)

Aggregated information

-           Aggregated   volume

-           Price

 

31,871

DKK 0.00

e)

Date of the   transaction

2021-11-12

f)

Place of the   transaction

Outside a trading venue

  

1.

Details of the   person discharging managerial responsibilities/person closely associated  

a)

Name

Henrik Birk

2.

Reason for the   notification

a)

Position/status

 

Executive Vice President and Chief Operating Officer   of Bavarian Nordic A/S

b)

Initial   notification/Amendment

Initial notification

3.

Details of the   issuer, emission allowance market participant, auction platform, auctioneer   or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the   transaction(s): section to be repeated for (i) each type of instrument; (ii)   each type of transaction; (iii) each date; and (iv) each place where   transactions have been conducted

a)

Description of   the financial instrument, type of instrument
 
 

Identification   code

Warrants


 
  DK0015998017

b)

Nature of the transaction

Grant

c)

Price(s) and   volume(s)

Price(s)

Volume(s)

 

 

DKK 0.00

29,425

d)

Aggregated information

-           Aggregated   volume

-           Price

 

29,425

DKK 0.00

e)

Date of the   transaction

2021-11-12

f)

Place of the   transaction

Outside a trading venue

  

1.

Details of the   person discharging managerial responsibilities/person closely associated  

a)

Name

Jean-Christophe May

2.

Reason for the   notification

a)

Position/status

 

Executive Vice President and Chief Commercial   Officer of Bavarian Nordic A/S

b)

Initial   notification/Amendment

Initial notification

3.

Details of the   issuer, emission allowance market participant, auction platform, auctioneer   or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s):   section to be repeated for (i) each type of instrument; (ii) each type of   transaction; (iii) each date; and (iv) each place where transactions have   been conducted

a)

Description of   the financial instrument, type of instrument
 
 

Identification   code

Warrants


 
  DK0015998017

b)

Nature of the   transaction

Grant

c)

Price(s) and   volume(s)

Price(s)

Volume(s)

 

 

DKK 0.00

30,217

d)

Aggregated information

-           Aggregated   volume

-           Price

 

30,217

DKK 0.00

e)

Date of the   transaction

2021-11-12

f)

Place of the   transaction

Outside a trading venue

  

1.

Details of the   person discharging managerial responsibilities/person closely associated  

a)

Name

Laurence De Moerlooze

2.

Reason for the   notification

a)

Position/status

 

Executive Vice President and Chief Medical Officer   of Bavarian Nordic A/S

b)

Initial   notification/Amendment

Initial notification

3.

Details of the   issuer, emission allowance market participant, auction platform, auctioneer   or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the   transaction(s): section to be repeated for (i) each type of instrument; (ii)   each type of transaction; (iii) each date; and (iv) each place where   transactions have been conducted

a)

Description of   the financial instrument, type of instrument
 
 

Identification   code

Warrants


 
  DK0015998017

b)

Nature of the transaction

Grant

c)

Price(s) and   volume(s)

Price(s)

Volume(s)

 

 

DKK 0.00

27,687

d)

Aggregated information

-           Aggregated   volume

-           Price

 

27,687

DKK 0.00

e)

Date of the   transaction

2021-11-12

f)

Place of the   transaction

Outside a trading venue

  

1.

Details of the   person discharging managerial responsibilities/person closely associated  

a)

Name

Anu Helena Kerns

2.

Reason for the   notification

a)

Position/status

 

Executive Vice President People & Organization   of Bavarian Nordic A/S

b)

Initial   notification/Amendment

Initial notification

3.

Details of the   issuer, emission allowance market participant, auction platform, auctioneer   or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s):   section to be repeated for (i) each type of instrument; (ii) each type of   transaction; (iii) each date; and (iv) each place where transactions have   been conducted

a)

Description of   the financial instrument, type of instrument
 
 

Identification   code

Warrants


 
  DK0015998017

b)

Nature of the   transaction

Grant

c)

Price(s) and   volume(s)

Price(s)

Volume(s)

 

 

DKK 0.00

21,459

d)

Aggregated information

-           Aggregated   volume

-           Price

 

21,459

DKK 0.00

e)

Date of the   transaction

2021-11-12

f)

Place of the   transaction

Outside a trading venue

  

About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacturing and commercialization of life-saving vaccines. We are a global leader in smallpox vaccines and have been a long-term supplier to the U.S. Government of a non-replicating smallpox vaccine, which has been approved by the FDA, also for the protection against monkeypox. The vaccine is approved as a smallpox vaccine in Europe and Canada. Our commercial product portfolio furthermore contains market-leading vaccines against rabies and tick-borne encephalitis. Using our live virus vaccine platform technology, MVA-BN®, we have created a diverse portfolio of proprietary and partnered product candidates designed to save and improve lives by unlocking the power of the immune system, including an Ebola vaccine, which is licensed to the Janssen Pharmaceutical Companies of Johnson & Johnson. We are also committed to the development of a next generation COVID-19 vaccine. For more information visit www.bavarian-nordic.com.

Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600 

Company Announcement no. 36 / 2021

Published on November 12, 2021, 17:30 CET